InnovAge Holding Corp (INNV)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $1.29B
Last updated: Nov 17, 2026 at 11:05 AM ET
InnovAge Holding Corp (INNV) Financials: Revenue, Profit and Cash Flow
InnovAge Holding reported revenue of $989.71M for the fiscal year ended Jun 30, 2026, up 15.9% from the year before. That year, net income was -$683.00K with a net margin of -0.1%, operating cash flow was $64.71M and free cash flow was $50.41M. The quarter ended Sep 30, 2026 had revenue of $264.76M and net income of $20.88M.
Revenue and Margins
The operating margin was 0.3% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from $4.82M, a compound annual rate of 80.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $989.71M | +15.9% | 68.5% | 0.3% | -0.1% |
| Jun 2025 | $853.70M | +11.8% | 68.5% | -3.5% | -4.1% |
| Jun 2024 | $763.86M | +11.0% | 70.0% | -3.0% | -3.0% |
| Jun 2023 | $688.09M | -1.5% | 69.2% | -7.2% | -6.3% |
| Jun 2022 | $698.64M | +9.5% | 74.2% | -0.6% | -1.1% |
| Jun 2021 | $637.80M | N/A | 75.8% | -1.9% | -7.0% |
| Jun 2020 | $0 | -100.0% | N/A | N/A | N/A |
| Jun 2019 | $465.63M | +5181.5% | 23.8% | 8.5% | 4.2% |
| Jun 2018 | $8.82M | +83.0% | 79.0% | -57.8% | -73.8% |
| Jun 2017 | $4.82M | N/A | 77.5% | -121.1% | -284.3% |
Income Statement
In the fiscal year ended Jun 2026, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income rose 172.2% from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $989.71M | $853.70M | $763.86M | $688.09M | $698.64M | $637.80M | $0 | $465.63M | $8.82M | $4.82M |
| Cost of revenue | $312.10M | $268.91M | $228.78M | $212.27M | $180.22M | $154.40M | $153.06M | $355.00M | $1.85M | $1.08M |
| Gross profit | $677.61M | $584.79M | $535.07M | $475.82M | $518.42M | $483.40M | -$153.06M | $110.63M | $6.97M | $3.74M |
| Research and development | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $160.00K | $38.81K | $77.80K |
| Operating income | $2.62M | -$29.76M | -$23.18M | -$49.40M | -$4.41M | -$12.34M | $50.93M | $39.67M | -$5.10M | -$5.83M |
| Net income | -$683.00K | -$35.34M | -$23.22M | -$43.55M | -$7.96M | -$44.74M | $52.04M | $19.58M | -$6.50M | -$13.70M |
| EBITDA | $26.44M | -$8.08M | -$1.26M | -$33.42M | $9.64M | N/A | $62.09M | $45.92M | N/A | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264.76M | $261.95M | $251.94M | $239.71M | $236.10M | $221.42M | $218.14M | $209.00M | $205.14M | $199.40M | $193.07M | $188.90M |
| Gross profit | $179.26M | $178.30M | $174.27M | $164.82M | $160.22M | $149.46M | $148.64M | $144.94M | $141.75M | $139.27M | $133.99M | $134.58M |
| Operating income | $20.15M | $10.15M | -$29.08M | $13.26M | $8.29M | -$2.15M | -$10.16M | -$12.56M | -$4.90M | -$4.88M | -$5.79M | -$1.78M |
| Net income | $20.88M | $9.78M | -$29.94M | $11.80M | $7.67M | -$5.01M | -$11.13M | -$13.49M | -$5.71M | -$2.25M | -$6.18M | -$3.82M |
Balance Sheet
As of Jun 2026, cash and equivalents exceeded total debt of $48.06M by $49.83M.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $557.39M | $526.85M | $547.66M | $567.36M | $555.60M | $531.75M | $409.63M | $363.23M | $9.03M | $8.23M |
| Current assets | $214.31M | $176.11M | $173.14M | $215.23M | $240.96M | $250.93M | $166.93M | $119.45M | $3.72M | $2.33M |
| Cash and equivalents | $97.89M | $64.13M | $56.95M | $127.25M | $184.43M | $201.47M | $112.90M | $61.20M | $1.56M | $829.93K |
| Total liabilities | $288.62M | $263.94M | $247.85M | $252.56M | $201.85M | $173.79M | $301.88M | $281.79M | $8.13M | $7.13M |
| Short-term debt | $2.54M | $2.25M | $3.79M | $3.79M | $3.79M | $3.79M | $3.73M | $3.63M | $1.30M | $1.34M |
| Long-term debt | $45.52M | $57.46M | $61.48M | $64.84M | $68.21M | $71.57M | $210.43M | $186.82M | N/A | $54.52K |
| Shareholder equity | $235.60M | $234.97M | $269.26M | $296.30M | $332.36M | $334.56M | $101.02M | $74.19M | $902.94K | $1.09M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $562.96M | $557.39M | $547.39M | $527.48M | $510.23M | $557.23M | $536.65M | $524.78M | $527.72M | $579.84M | $527.36M | $534.26M |
| Total liabilities | $273.75M | $288.62M | $288.50M | $238.72M | $234.47M | $294.32M | $268.94M | $246.83M | $237.01M | $280.03M | $229.03M | $231.29M |
| Cash and equivalents | $119.25M | $97.89M | $95.54M | $83.20M | $67.15M | $64.14M | $60.45M | $46.08M | $39.02M | $56.96M | $54.09M | $54.08M |
| Shareholder equity | $255.34M | $235.60M | $229.03M | $256.79M | $244.98M | $234.97M | $237.96M | $248.46M | $260.94M | $269.26M | $281.15M | $285.50M |
Cash Flow
In the fiscal year ended Jun 2026, free cash flow was 77.9% of operating cash flow. Dividends came to 3.2% of it, with no share repurchases.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $64.71M | $32.87M | -$36.90M | $20.24M | $27.30M | -$7.55M | $43.83M | $25.91M | -$2.36M | -$1.78M |
| Capital expenditures | $14.31M | $6.26M | $7.91M | $23.35M | $38.24M | $17.54M | $11.84M | $14.49M | $44.64K | $45.00K |
| Free cash flow | $50.41M | $26.60M | -$44.81M | -$3.12M | -$10.94M | -$25.09M | $31.98M | $11.42M | -$2.41M | -$1.83M |
| Dividends paid | $1.63M | $0 | N/A | N/A | $0 | $9.50M | $0 | $66.51M | N/A | N/A |
| Share repurchases | $0 | $7.32M | $179.00K | $0 | N/A | $77.60M | $0 | N/A | N/A | N/A |
| Investing cash flow | -$12.34M | -$5.55M | -$26.37M | -$69.52M | -$40.24M | -$19.54M | -$11.69M | -$52.48M | -$58.00K | -$172.10K |
| Financing cash flow | -$18.53M | -$19.08M | -$7.03M | -$7.90M | -$6.32M | $116.22M | $21.23M | $37.35M | -$3.15M | $2.73M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $28.74M | $21.29M | $18.14M | $21.36M | $3.92M | $9.00M | $24.63M | $6.75M | -$7.52M | $1.87M | $3.51M | -$9.29M |
| Capital expenditures | $2.99M | $4.27M | $3.60M | $2.36M | $4.08M | $179.00K | $2.90M | $1.34M | $2.20M | $3.31M | $452.00K | $1.59M |
| Free cash flow | $25.75M | $17.02M | $14.54M | $19.00M | -$153.00K | $8.82M | $21.73M | $5.41M | -$9.72M | -$1.43M | $3.06M | -$10.88M |
Frequently Asked Questions About INNV
What is InnovAge Holding's annual revenue?
InnovAge Holding reported revenue of $989.71M for the fiscal year ended Jun 30, 2026.
How fast is InnovAge Holding's revenue growing?
Revenue was up 15.9% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 12.9%.
Is InnovAge Holding profitable?
No. InnovAge Holding reported net income of -$683.00K for the fiscal year ended Jun 30, 2026, with a net margin of -0.1%.
How much free cash flow does INNV generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of $64.71M minus capital expenditures of $14.31M produced free cash flow of $50.41M.
How much debt does InnovAge Holding have?
The balance sheet dated Jun 30, 2026 reported long-term debt of $45.52M, short-term debt of $2.54M and cash and equivalents of $97.89M.
INNV pages: Overview, Earnings, Forecast, Financials, Valuation